Shanghai Jianfa Zhixin Medical Technology Group Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the information disclosed is true, accurate, complete, and free from false records, misleading statements, or significant omissions.
On April 17, 2026, the Company held the 14th meeting of the 3rd Board of Directors, where it reviewed and approved the proposal regarding the application for a comprehensive credit line from banks for 2026. This proposal is subject to approval by the Company's shareholders' meeting, and the relevant matters are announced as follows: